DYRK1A and leukemia: Several studies have shown that in some tissues in mouse models, increased expression of a single additional allele within Hsa21, Dyrk1a, for example, is sufficient to produce changes in stem/progenitor cell behavior, which correlates with clinical phenotypic observations, such as leukemia and cognitive defects [18].